2637.HK (Fujian Haixi Pharmaceuticals Co., Ltd.) is a recent IPO.
It began trading on December 8, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.
The latest headlines, third-party analysis, and SEC filings for Fujian Haixi Pharmaceuticals Co., Ltd. (2637.HK) are listed on this page. Headlines come from across the financial press; filings come directly from SEC EDGAR.
Where are 2637.HK's SEC filings?
Fujian Haixi Pharmaceuticals Co., Ltd. (2637.HK)'s 10-K (annual report), 10-Q (quarterly report), 8-K (current report), and proxy filings are listed in the SEC Filings section on this page with direct links to the official EDGAR copies.
Where are 2637.HK's earnings call transcripts?
Full earnings call transcripts for Fujian Haixi Pharmaceuticals Co., Ltd. (2637.HK) — prepared remarks plus speaker-by-speaker analyst Q&A — live on the Earnings tab, alongside the Earnings Reports section that links each quarter's press release and SEC report.
